Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?

Area of Science:

• Oncology
• Endocrinology
• Gynecology

Background:

• Hormone therapy is a key treatment for gynecological cancers, targeting hormone-dependent tumor growth.
• Medications used include aromatase inhibitors, anti-estrogens, progestins, and GnRH agonists.
• Hormone replacement therapy shows promise, particularly in HPV-infected women, potentially decreasing cancer incidence.

Purpose of the Study:

• To review the current applications of hormone therapy in gynecological cancers.
• To identify knowledge gaps and areas for future research in hormonal treatments.

Main Methods:

• Review of existing literature on hormone therapy for vulvar, cervical, vaginal, uterine, and ovarian cancers.
• Analysis of therapeutic outcomes and response rates for various hormonal agents.

Main Results:

• Hormonal agents like progestogen and estrogen replacement show potential benefits, especially in HPV-positive individuals.
• Hormone therapy is a common approach for hormone-sensitive recurrent or metastatic gynecologic malignancies.
• Inconsistent response rates and therapeutic outcomes necessitate further investigation.

Conclusions:

• Hormone therapy remains a significant treatment modality for gynecological cancers.
• Further research is needed to optimize hormonal treatments and address inconsistent outcomes.
• Understanding the interplay between HPV and estrogen receptor signaling is crucial for advancing therapy.